Oxidative stress in multiple sclerosis: Central and peripheral mode of action

被引:241
作者
Ohl, Kim [1 ]
Tenbrock, Klaus [1 ]
Kipp, Markus [2 ]
机构
[1] Rhein Westfal TH Aachen, Fac Med, Dept Pediat, Pauwelsstr 30, D-52074 Aachen, Germany
[2] Univ Munich, Dept Anat 2, D-80336 Munich, Germany
关键词
Neurodegeneration; Nrf2; DMF; Neuroprotection; REGULATORY T-CELLS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; ELEMENT SIGNALING PATHWAY; TRANSCRIPTION FACTOR NRF2; NF-KAPPA-B; DENDRITIC CELLS; IN-VITRO; INDUCIBLE EXPRESSION; HYDROGEN-PEROXIDE; SUPPRESSOR-CELLS;
D O I
10.1016/j.expneurol.2015.11.010
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Accumulating evidence suggests that oxidative stress plays a major role in the pathogenesis of multiple sclerosis (MS). Reactive oxygen species (ROS), which if produced in excess lead to oxidative stress, have been implicated as mediators of demyelination and axonal damage in both MS and its animal models. One of the most studied cell populations in the context of ROS-mediated tissue damage in MS are macrophages and their CNS companion, microglia cells. However, and this aspect is less well appreciated, the extracellular and intracellular redox milieu is integral to many processes underlying T cell activation, proliferation and apoptosis. In this review article we discuss how oxidative stress affects central as well as peripheral aspects of MS and how manipulation of ROS pathways can potentially affect the course of the disease. It is our strong belief that the well-directed shaping of ROS pathways has the potential to ameliorate disease progression in MS. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:58 / 67
页数:10
相关论文
共 50 条
  • [41] The central role of mitochondria in axonal degeneration in multiple sclerosis
    Campbell, Graham R.
    Worrall, Joseph T.
    Mahad, Don J.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (14) : 1806 - 1813
  • [42] Molecular Mechanisms of the Action of Vitamin A in Th17/Treg Axis in Multiple Sclerosis
    Abdolahi, Mina
    Yavari, Parvaneh
    Honarvar, Niyaz Mohammadzadeh
    Bitarafan, Sama
    Mahmoudi, Maryam
    Saboor-Yaraghi, Ali Akbar
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2015, 57 (04) : 605 - 613
  • [43] Glatiramer Acetate in the Treatment of Multiple Sclerosis Emerging Concepts Regarding its Mechanism of Action
    Lalive, Patrice H.
    Neuhaus, Oliver
    Benkhoucha, Mandia
    Burger, Danielle
    Hohlfeld, Reinhard
    Zamvil, Scott S.
    Weber, Martin S.
    CNS DRUGS, 2011, 25 (05) : 401 - 414
  • [44] Oxidative damage in multiple sclerosis lesions
    Haider, Lukas
    Fischer, Marie T.
    Frischer, Josa M.
    Bauer, Jan
    Hoeftberger, Romana
    Botond, Gergoe
    Esterbauer, Harald
    Binder, Christoph J.
    Witztum, Joseph L.
    Lassmann, Hans
    BRAIN, 2011, 134 : 1914 - 1924
  • [45] Peripheral blood biomarkers in multiple sclerosis
    D'Ambrosio, Antonella
    Pontecorvo, Simona
    Colasanti, Tania
    Zamboni, Silvia
    Francia, Ada
    Margutti, Paola
    AUTOIMMUNITY REVIEWS, 2015, 14 (12) : 1097 - 1110
  • [46] Potential Utility of Natural Products against Oxidative Stress in Animal Models of Multiple Sclerosis
    Zha, Zheng
    Liu, Sisi
    Liu, Yijiang
    Li, Chen
    Wang, Lei
    ANTIOXIDANTS, 2022, 11 (08)
  • [47] Dual Mechanism of Action of Curcumin in Experimental Models of Multiple Sclerosis
    ELBini-Dhouib, Ines
    Manai, Maroua
    Neili, Nour-Elhouda
    Marzouki, Soumaya
    Sahraoui, Ghada
    Ben Achour, Warda
    Zouaghi, Sondes
    BenAhmed, Melika
    Doghri, Raoudha
    Srairi-Abid, Najet
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (15)
  • [48] Mechanisms of Oxidative Damage in Multiple Sclerosis and Neurodegenerative Diseases: Therapeutic Modulation via Fumaric Acid Esters
    Lee, De-Hyung
    Gold, Ralf
    Linker, Ralf A.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2012, 13 (09) : 11783 - 11803
  • [49] The NLRP3 inflammasome: A central player in multiple sclerosis
    Otalora-Alcaraz, Almudena
    Reilly, Thomas
    Oro-Nolla, Marti
    Sun, Melody Cui
    Costelloe, Lisa
    Kearney, Hugh
    Patra, Pabitra H.
    Downer, Eric J.
    BIOCHEMICAL PHARMACOLOGY, 2025, 232
  • [50] Modulating processes within the central nervous system is central to therapeutic control of multiple sclerosis
    Tjalf Ziemssen
    Journal of Neurology, 2005, 252 : v38 - v45